Genmab — September 2020
-
Jan has certainly given us the impression that the SC administration would prolong the GEN royalty stream
-
That kind of communication opens the company up to all sorts of litigation if it is not so
-
I wonder if it is the AbbVie deal that has pissed JJ off so much?
-
Mon ikke bare det er et bump på vejen. Kurs 3000 Q1 - 2020 ? . Vurder selv. Kanalen er bare blevet lidt bredere
https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/86975_bump.JPG -
UBS og Jefferies beholder deres købsanbefaling og målkurser på hhv. 2540 og 2800. Bryan Garnier downgrader til sælg uden målkurs.
-
I’m not sure about the 5% share to HALO - but certainly about the prolonged revenue stream
-
Tror ikke det er vigtigt her @lahn, det er et tveægget sværd som de har glemt at gardere sig imod. De kan umuligt vinde begge punkter da det ene punkt modsiger det andet eller mere klart de er skakmat. De må vælge hvor de taber mindst. De kan nok vinde begge tviste hver for sig, men ikke sammen er mit gæt for den tvist de vinder først vil blive brugt mod dem selv i tvist 2.
-
It seems that JJ wants it both ways - one, they want GEN to pay 5% to HALO - two, they want to cut the royalty period significantly
-
That is fighting talk
-
Could be all of the above. This kind of crap is poison for the stock - short term and long term
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind